2019 Outpatient Prospective Payment System Update
December 7, 2018
9 a.m. - 12 p.m.
MHA Conference Center
Significant changes are coming that will affect hospital reimbursement for outpatient services, Part B drugs, telehealth services, physician visits, as well as the 340B drug discount program. Please join us to review key changes in the 2019 Medicare Outpatient Prospective Payment System final rule, as well as focus on items of note in the 2019 Medicare Physician Fee Schedule final rule. We will also cover hospital price transparency requirements effective in 2019, pending proposals concerning drug pricing, and we'll feature a special Washington update that will include discussion of the current political climate, its likely impact on hospitals, and considerations on the future of drug pricing.
We’ll look at:
-Site Neutral Payment & Section 603
-Volume-Control Method: Site Neutral Payment for Off-Campus Clinic Visits
-340B Drug Payments
-Hospital Price Transparency Requirement
-PFS Overview, Including Telehealth and E&M Code Collapse
-Drug Pricing Proposals from CMS and the Hill
-Update from Washington D.C.
Faculty from Hooper, Lundy & Bookman, PC:
Hooper, Lundy & Bookman, PC believes that the complexity of health care law requires a depth of understanding that goes beyond that commonly found in general practice firms with health care law departments. Such depth can only be achieved through industry specialization and experience. That is why they have dedicated their practice since its inception in 1987 exclusively to understanding the intricacies of the health care industry. The firm has represented clients in many of the landmark appellate cases that have shaped health care law over the past two decades.